4 Healthcare Stock Stories Not To Be Overlooked on TGIF

St. Jude Medical (NYSE:STJ): Closing price $42.25

On Friday, the medical device firm, announced the first patient implant in a new pivotal trial studying its Amplatzer Cardiac Plug for the prevention of stroke. The trial was created to determine if the plug is safe and effective in preventing thrombus (blood clots) from migrating out of the left atrial appendage in patients with non-valvular atrial fibrillation who have a high risk for stroke. The ACP Trial is a prospective, randomized, multi-center clinical study having an adaptive trial design that will enroll no fewer than 400 and no more than 3,000 patients at as many as 90 sites in the United States and in Canada.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.